{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T10:39:14Z","timestamp":1720262354787},"reference-count":21,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2018.1637","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T09:37:39Z","timestamp":1526895459000},"source":"Crossref","is-referenced-by-count":3,"title":["FIP1L1\u2011PDGFRA fusion\u2011negative hypereosinophilic syndrome with uncommon cardiac involvement responding to imatinib treatment: A case report"],"prefix":"10.3892","author":[{"given":"Amanda","family":"Dal Berto","sequence":"first","affiliation":[{"name":"Santa Terezinha University Hospital, Joa\u00ef\u00bf\u00bdaba, Santa Catarina 89600\u2011000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Cami\u00ef\u00bf\u00bda","sequence":"additional","affiliation":[{"name":"Santa Terezinha University Hospital, Joa\u00ef\u00bf\u00bdaba, Santa Catarina 89600\u2011000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Machado","sequence":"additional","affiliation":[{"name":"Santa Terezinha University Hospital, Joa\u00ef\u00bf\u00bdaba, Santa Catarina 89600\u2011000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antuani","family":"Baptistella","sequence":"additional","affiliation":[{"name":"Santa Terezinha University Hospital, Joa\u00ef\u00bf\u00bdaba, Santa Catarina 89600\u2011000, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"key20200713201908_b1-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.iac.2015.05.006","article-title":"Management of hypereosinophilic syndromes","volume":"35","author":"Roufosse","year":"2015","journal-title":"Immunol Allergy Clin N Am"},{"key":"key20200713201908_b2-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"key20200713201908_b3-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion","year":"2015","journal-title":"Blood"},{"key":"key20200713201908_b4-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.7326\/0003-4819-68-6-1220","article-title":"The hypereosinophilic syndromes","volume":"68","author":"Hardy","year":"1968","journal-title":"Ann Intern Med"},{"key":"key20200713201908_b5-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/heartjnl-2015-307959","article-title":"Hypereosinophilic syndrome: Cardiac diagnosis and management","volume":"102","author":"Mankad","year":"2016","journal-title":"Heart"},{"key":"key20200713201908_b6-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1586\/ehm.12.14","article-title":"Clinical management of the hypereosinophilic syndromes","volume":"5","author":"Cogan","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"key20200713201908_b7-mco-0-0-1637","first-page":"177","article-title":"S\u00edndrome hipereosinof\u00edlica idiop\u00e1tica","volume":"8","author":"Ronchi Junior","year":"2010","journal-title":"Relato de caso e revis\u00e3o de literatura. Rev Bras Clin Med"},{"key":"key20200713201908_b8-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/cncr.22920","article-title":"A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia","volume":"110","author":"Kalac","year":"2007","journal-title":"Cancer"},{"key":"key20200713201908_b9-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1365-2141.2003.04195.x","article-title":"The eosinophilias, including the idiopathic hypereosinophilic syndrome","volume":"121","author":"Brito-Babapulle","year":"2003","journal-title":"Br J Haematol"},{"key":"key20200713201908_b10-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"e635","DOI":"10.1161\/CIRCULATIONAHA.106.636753","article-title":"Images in cardiovascular medicine. Early differential resolution of right and left ventricular obliteration in L\u00f6ffler endocarditis after chemotherapy and anticoagulation","volume":"114","author":"Benezet-Mazuecos","year":"2006","journal-title":"Circulation"},{"key":"key20200713201908_b11-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12016-015-8506-7","article-title":"Hypereosinophilic syndrome","volume":"50","author":"Curtis","year":"2016","journal-title":"Clinic Rev Allerg Immunol"},{"key":"key20200713201908_b12-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"key20200713201908_b13-mco-0-0-1637","article-title":"Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1","volume-title":"World Health Organization classification of tumors of hematopoietic and lymphoid tissues: 68\u201373","author":"Bain","year":"2008"},{"key":"key20200713201908_b14-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"key20200713201908_b15-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/ajh.24196","article-title":"World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management","volume":"90","author":"Gotlib","year":"2015","journal-title":"Am J Hematol"},{"key":"key20200713201908_b16-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3324\/haematol.11420","article-title":"The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study","volume":"92","author":"Baccarani","year":"2007","journal-title":"Haematologica"},{"key":"key20200713201908_b17-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2141.2008.07294.x","article-title":"Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: A phase-II study","volume":"143","author":"Metzgeroth","year":"2008","journal-title":"Br J Haematol"},{"key":"key20200713201908_b18-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/all.12843","article-title":"Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome","volume":"71","author":"Khoury","year":"2016","journal-title":"Allergy"},{"key":"key20200713201908_b19-mco-0-0-1637","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"key20200713201908_b20-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.athoracsur.2011.08.062","article-title":"Unusual cause of acute mitral regurgitation: Idiopathic hypereosinophilic syndrome","volume":"93","author":"Madhwal","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"key20200713201908_b21-mco-0-0-1637","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4250\/jcu.2015.23.2.100","article-title":"A hypereosinophilic syndrome with cardiac involvement from thrombotic stage to fibrotic stage","volume":"23","author":"Kim","year":"2015","journal-title":"J Cardiovasc Ultrasound"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:19:13Z","timestamp":1594667953000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2018.1637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":21,"URL":"https:\/\/doi.org\/10.3892\/mco.2018.1637","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]}}}